Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
13.63
Dollar change
-0.02
Percentage change
-0.15
%
Index- P/E17.25 EPS (ttm)0.79 Insider Own- Shs Outstand26.21M Perf Week0.44%
Market Cap357.27M Forward P/E- EPS next Y- Insider Trans- Shs Float26.21M Perf Month-1.94%
Income- PEG- EPS next Q- Inst Own34.00% Short Float0.51% Perf Quarter0.22%
Sales3.51M P/S101.70 EPS this Y- Inst Trans- Short Ratio1.13 Perf Half Y9.57%
Book/sh16.12 P/B0.85 EPS next Y- ROA- Short Interest0.13M Perf Year2.51%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range11.34 - 14.37 Perf YTD1.26%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-5.15% Beta0.71
Dividend TTM1.01 (7.41%) Quick Ratio- Sales past 5Y- Gross Margin- 52W Low20.19% ATR (14)0.16
Dividend Ex-DateFeb 21, 2024 Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)48.59 Volatility0.78% 1.20%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q- Payout149.35% Rel Volume0.53 Prev Close13.65
Sales Surprise- EPS Surprise- Sales Q/Q34.40% Earnings- Avg Volume118.54K Price13.63
SMA20-0.14% SMA50-1.20% SMA2003.81% Trades Volume63,345 Change-0.15%
Mar-28-24 04:17PM
Mar-21-24 07:59AM
Feb-09-24 05:23PM
Jan-10-24 04:17PM
Oct-27-23 05:20PM
04:57PM Loading…
04:57PM
04:57PM
Oct-13-23 06:26PM
Oct-05-23 02:05PM
Sep-29-23 10:35AM
Sep-25-23 09:01PM
Sep-21-23 05:01AM
Sep-13-23 08:51AM
Aug-30-23 02:39PM
Aug-15-23 09:55AM
03:10PM Loading…
Aug-14-23 03:10PM
Jun-30-23 10:35AM
Jun-20-23 06:15PM
05:48PM
May-15-23 10:36AM
Mar-31-23 09:55AM
09:55AM
09:55AM
09:55AM
Mar-16-23 02:40PM
Feb-15-23 10:33AM
Dec-30-22 09:55AM
09:55AM
09:55AM
09:55AM
09:56AM Loading…
Nov-15-22 09:56AM
Sep-30-22 10:22AM
Aug-16-22 10:10AM
Jul-29-22 10:35AM
10:35AM
Jun-30-22 11:10AM
11:10AM
11:10AM
11:10AM
May-17-22 11:38AM
Mar-31-22 10:52AM
Mar-22-22 10:23AM
Feb-28-22 10:54AM
10:54AM
Feb-15-22 01:15PM
Jan-31-22 11:08AM
11:07AM
Dec-31-21 10:21AM
10:20AM
10:20AM
10:20AM
Nov-30-21 02:24PM
02:24PM
Nov-12-21 12:28PM
Oct-29-21 11:17AM
11:17AM
Sep-30-21 10:34AM
10:34AM
10:34AM
10:34AM
Aug-31-21 11:05AM
11:05AM
Aug-17-21 11:10AM
Jul-30-21 11:58AM
11:58AM
Jun-30-21 10:17AM
10:17AM
10:16AM
10:16AM
May-28-21 10:25AM
10:25AM
May-18-21 10:26AM
Apr-30-21 02:10PM
02:10PM
Mar-31-21 10:52AM
10:51AM
10:46AM
10:43AM
Mar-25-21 04:10PM
Feb-26-21 12:10PM
12:10PM
Feb-16-21 10:36AM
Jan-29-21 11:35AM
11:35AM
Jan-06-21 01:06PM
Dec-31-20 10:25AM
10:25AM
10:25AM
10:25AM
Dec-21-20 04:21PM
Nov-30-20 11:30AM
11:30AM
Nov-16-20 11:03AM
Oct-30-20 10:45AM
10:45AM
Oct-02-20 08:23PM
Sep-30-20 01:30PM
01:30PM
01:30PM
01:30PM
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reit ToddDirectorJan 02 '24Buy13.801,00013,7981,000Jan 04 02:23 PM
Maher BillDirectorDec 28 '23Buy13.571,00013,5701,000Jan 02 04:34 PM
OMSTEAD DANIEL RPresidentSep 25 '23Buy12.3910,096125,116197,518Sep 25 05:35 PM
OMSTEAD DANIEL RPresidentSep 20 '23Buy12.6812,000152,206187,422Sep 20 06:40 PM